118 related articles for article (PubMed ID: 37787316)
21. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
[TBL] [Abstract][Full Text] [Related]
23. Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix.
Baalbergen A; Veenstra Y; Stalpers L
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD006248. PubMed ID: 23440805
[TBL] [Abstract][Full Text] [Related]
24. Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes.
DeBoer RJ; Umutoni V; Bazzett-Matabele L; Katznelson E; Nguyen C; Umwizerwa A; Bigirimana JB; Paciorek A; Nsabimana N; Ruhangaza D; Ntasumbumuyange D; Shulman LN; Triedman SA; Shyirambere C
Gynecol Oncol; 2022 Feb; 164(2):370-378. PubMed ID: 34916066
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin versus gemcitabine as concurrent chemoradiotherapy in squamous cell carcinoma cervix: A comparative study of clinical response and toxicities.
Singh R; Singh Banipal RP; Goyal LD
J Cancer Res Ther; 2022; 18(6):1518-1524. PubMed ID: 36412403
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
28. Clinical profile and treatment outcome of collision carcinoma in cervix.
Shu P; Li R; Xie D; He Y; Wang X; Li Q
Medicine (Baltimore); 2020 Mar; 99(11):e19131. PubMed ID: 32176038
[TBL] [Abstract][Full Text] [Related]
29. Long-term results and prognostic factors in patients with stage III-IVA squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy from a single institution study.
Kudaka W; Nagai Y; Toita T; Inamine M; Asato K; Nakamoto T; Wakayama A; Ooyama T; Tokura A; Murayama S; Aoki Y
Int J Clin Oncol; 2013 Oct; 18(5):916-21. PubMed ID: 22898910
[TBL] [Abstract][Full Text] [Related]
30. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix.
Roberts KB; Urdaneta N; Vera R; Vera A; Gutierrez E; Aguilar Y; Ott S; Medina I; Sempere P; Rockwell S; Sartorelli AC; Fischer DB; Fischer JJ
Int J Cancer; 2000 Aug; 90(4):206-23. PubMed ID: 10993961
[TBL] [Abstract][Full Text] [Related]
31. Does Microinvasive Adenocarcinoma of Cervix Have Poorer Treatment Outcomes than Microinvasive Squamous Cell Carcinoma?
Ruengkhachorn I; Hanamornroongruang S; Leelaphatanadit C; Sangkarat S
Asian Pac J Cancer Prev; 2016; 17(8):4013-7. PubMed ID: 27644654
[TBL] [Abstract][Full Text] [Related]
32. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
[TBL] [Abstract][Full Text] [Related]
33. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
Ma SK; Wu LY; Sun YC; Li B; Zhang HT
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
[TBL] [Abstract][Full Text] [Related]
34. Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery.
Zhang X; Lv Z; Xu X; Yin Z; Lou H
BMC Cancer; 2020 Jul; 20(1):664. PubMed ID: 32678039
[TBL] [Abstract][Full Text] [Related]
35. Preoperative Chemoradiotherapy in Locally Advanced Bulky Squamous Cell Carcinoma of the Uterine Cervix.
Nakao Y; Hashiguchi M; Nishiyama S; Aihara S; Iwasaka T; Yokoyama M
Int J Gynecol Cancer; 2017 Nov; 27(9):1943-1948. PubMed ID: 28786876
[TBL] [Abstract][Full Text] [Related]
36. [13-cis retinoic acid and interferon-alfa-2a as palliative therapy in pretreated, recurrent squamous epithelial carcinoma of the cervix uteri and vulva].
Römisch M; Meier W; Kimmig R; Hepp H
Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):520-4. PubMed ID: 9036064
[TBL] [Abstract][Full Text] [Related]
37. Comparative assessment of late toxicity in patients of carcinoma cervix treated by radiotherapy versus chemo-radiotherapy - Minimum 5 years follow up.
Misra S; Lal P; Kumar Ep S; Rastogi N; Tiwari A; Singh S; Das KJM; Kumar S
Cancer Treat Res Commun; 2018; 14():30-36. PubMed ID: 30104006
[TBL] [Abstract][Full Text] [Related]
38. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.
Choi KH; Yu M; Jeong S; Lee JH
Int J Clin Oncol; 2020 Jul; 25(7):1405-1411. PubMed ID: 32221801
[TBL] [Abstract][Full Text] [Related]
39. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
40. [Squamous cell carcinoma of the uterine cervix at the Dakar Cancer Institute].
Dem A; Dieng MM; Traoré B; Gaye M; Diop M; Touré P
Sante; 2008; 18(1):31-3. PubMed ID: 18684688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]